Three neuronal-related genes (PCLO, PLXNA4, and EPHA7), and the gene encoding the leptin receptor (LEPR), all reported as mutated in melanoma at a variable frequency (37%, 11%, 16% and 8% of samples in TCGA cohort, respectively), were altered more frequently in R compared to NR patients. This evidence concerns the gene PCLO and melanoma.